YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

S.J. Antonia ; A. Villegas ; D. Daniel ; D. Vicente ; S. Murakami ; R. Hui ; ... NEW ENGLAND JOURNAL OF MEDICINE, Vol.377(20) : 1919-1929, 2017

This table browses all dspace content
Issue Date	Title	Journal Title
2026	Single-arm longitudinal study to assess changes in insula functional connectivity following a mobile-based lifestyle intervention in adults with metabolic abnormalities	JOURNAL OF PSYCHOSOMATIC RESEARCH
2026	Impact of treatment response to neoadjuvant chemotherapy on brain metastasis patterns and breast cancer prognosis	BREAST
2026	CADEM: Species-level detection of mycobacterial cfDNA via CRISPR for pulmonary disease diagnosis	ANALYTICA CHIMICA ACTA
2026	Impaired insulin secretion via the Wnt5a/β-catenin pathway contributes to diabetes development in pancreatic cancer	EXPERIMENTAL AND MOLECULAR MEDICINE
2026	Microbial Profiling of Saliva, Oral Rinse, Subgingival Plaque and GCF Reveals Site-Specific Dysbiosis in Periodontitis: A Within-Subject Comparison of 150 Participants	JOURNAL OF CLINICAL PERIODONTOLOGY
2026	Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy (EFFORT): A 24-week, randomized, open-label, multicenter trial	DIABETES OBESITY & METABOLISM
2026	Osimertinib Plus Savolitinib in Patients With EGFR-Mutated Advanced NSCLC With MET Alterations After First-Line Osimertinib: Clinical Outcomes, Safety, and Biomarker Analysis: A Brief Report	JOURNAL OF THORACIC ONCOLOGY
2026	Effect of tumour necrosis factor inhibitors on risk of depression in patients with AS: a nationwide propensity score-matched cohort study	RHEUMATOLOGY
2026	Differentiating Anderson-Fabry Disease from Other Causes of Left Ventricular Hypertrophy: Novel Insights from Left Atrial Strain Imaging	JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
2026	Prognostic implications of moderate aortic stenosis with concomitant aortic regurgitation in degenerative aortic valve disease: insights from a multicentre cohort	EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING
2026	Prospective Evaluation of Irreversible Electroporation With Clustered Electrodes as a Novel Palliative Approach for Locally Advanced Pancreatic Cancer	KOREAN JOURNAL OF RADIOLOGY
2026	Optimal Cutoffs of Fatty Liver Index and Hepatic Steatosis Index in Diagnosing Pediatric Metabolic Dysfunction-associated Steatotic Liver Disease	CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2026	Prognosis of Infective Endocarditis According to Clinical Characteristics, Economic Status, and Center Experience	YONSEI MEDICAL JOURNAL
2026	Impact of gross tumor morphology on the clinical outcomes of colon cancer: multicenter retrospective cohort study	INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
2026	Distinguishing Takayasu Arteritis and Giant Cell Arteritis Based on Large-Vessel Involvement Patterns	YONSEI MEDICAL JOURNAL
2026	Longitudinal Changes in Left Ventricular Geometry After Kidney Transplantation and Their Implications on Cardiovascular Risk	KIDNEY MEDICINE
2026	Serial next-generation sequencing for detecting germline predisposition in acute myeloid leukemia	HAEMATOLOGICA
2026	Peak oxygen consumption as a modifier of the obesity paradox in patients with obesity with heart failure with reduced ejection fraction	INTERNATIONAL JOURNAL OF OBESITY
2026	Real-world outcomes of inotuzumab ozogamicin treatment for adult relapsed or refractory acute lymphoblastic leukemia: a result from Korea post-marketing surveillance	ANNALS OF HEMATOLOGY
2026	Standardizing the Accuracy and Performance Evaluation Metrics of Integrated Continuous Glucose Monitors in the Asia-Pacific Region	DIABETES TECHNOLOGY & THERAPEUTICS